Neonatal Intensive Care Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The global neonatal intensive care market was valued at $2,012.4 million in 2021, and is projected to reach $4,403.0 million by 2031, registering a CAGR of 8.2% from 2022 to 2031.

A neonatal intensive care unit (NICU), also known as an intensive care nursery, is an intensive care unit that specializes in care of ill or premature newborn infants. The common equipment in a neonatal intensive care unit (NICU) include mechanical ventilators to assist breathing through an endotracheal tube or a tracheostomy tube; cardiac monitors for monitoring cardiac condition; equipment for constant monitoring of bodily functions; and a web of intravenous lines, feeding tubes, nasogastric tubes, and suction pumps.

Increase in birth rate and rise in number of preterm births boost growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2020, around 3,613,647 newborns were reported. Thus, increase in number of child birth and growth in number of preterm births drive growth of the market.

In addition, increase in incidences of maternity factors such as age of mother, alcoholism, and smoking is responsible for low growth rate and preterm delivery of baby, which further contributes toward growth of the market. Age-related factors such as being younger than 16 and older than age 40 contributes toward rise in underdeveloped child delivery rate. However, the rate of child marriage is slowly falling, owing to increase in awareness about child marriages and strict government initiatives. For instance, according to the United Nations Population Fund (UNFPA), in 2021, one in five women between the ages of 20 and 24 reported they had been married as children. From the same source, the total number of child marriages is projected to increase by 2030, owing to regional and socioeconomic factors.

Furthermore, increase in prevalence of chronic diseases such as diabetes and hypertension contribute toward growth of the market. Diabetes during pregnancy may be associated with a high rate of congenital anomalies, disturbances of intrauterine growth, and often post-natal neurobehavioral abnormalities in offspring. The latter are associated with pregestational (PGD) as well as with gestational diabetes (GD). This associated diseases in newborn may require special attention and admission in neonatal intensive care. For instance, according to the International Diabetes Federation (IDF), In 2021, approximately 537 million adults (20-79 years) were living with diabetes. and the number is projected to rise to 643 million by 2030 and 783 million by 2045.

Moreover, increase in R&D activities for development of advanced neonatal intensive cares such as advanced thermometer & oximeters, rise approvals from the in U.S. Food and Drug administration (USFDA), and novel product launches by key players boost the market growth. For instance, in December 2021, , U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Medtronic plc., a global leader in healthcare technology, for its INVOS 7100 cerebral/somatic oximetry system for children from birth through age 18. Furthermore, growing risk of COVID-19 infections in children propels demand for respiratory devices. However, high cost of neonatal intensive care and product recall hinder growth of the market.

The neonatal intensive care market is segmented on the basis of product, application, end user, and region. By product, the market is classified into warmers, incubators, monitoring devices, respiratory devices, phototherapy equipment, and others. The incubators segment is further divided into hybrid incubator, normal incubator, and transport incubator.

Depending on application the market is classified into neonatal hypothermia & low birth weight, jaundice, and others. By end user, it is categorized into hospitals, maternity hospitals, and neonatal & pediatric hospitals. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include: Dragerwerk AG & Co. KGaA, GE Company, Masimo Corporation, 3M Company, Phoenix Medical Systems Pvt Ltd., Medtronic PLC, Koninklijke Philips N.V, Fanem Medical Devices, Atom Medica, Mediprema Group, Siemens Healthcare GmbH, Terumo Corporation, Medicor Elektronika, Ningbo David Medical Device Co., Ltd., Zhengzhou Dison Instrument and Meter Co., Ltd, AngioDynamics, and Vygon (UK) Ltd.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the neonatal intensive care market analysis from 2021 to 2031 to identify the prevailing neonatal intensive care market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the neonatal intensive care market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global neonatal intensive care market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Warmers
Incubators
- Type
- Hybrid Incubator
- Normal Incubator
- Transport Incubator
Monitoring Devices
Respiratory Devices
Phototherapy Equipment
Others

By Application

Neonatal Hypothermia Low Birth Weight
Jaundice
Others

By End User

Hospitals
Maternity Hospitals
Neonatal Pediatric Hospital

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Italy
- Spain
- Rest of Europe
- Germany
- France
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Dragerwerk AG & Co. KGaA
- GE Company
- Masimo Corporation
- 3M Company
- Phoenix Medical Systems Pvt Ltd.
- Medtronic PLC
- Koninklijke Philips N.V
- Fanem Medical Devices
- Atom Medica
- Mediprema Group
- Siemens Healthcare GmbH
- Terumo Corporation
- Medicor Elektronika
- Ningbo David Medical Device Co., Ltd.
- Zhengzhou Dison Instrument And Meter Co., Ltd
- AngioDynamics
- Vygon (UK) Ltd

Product Code: A17086

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: NEONATAL INTENSIVE CARE MARKET, BY PRODUCT

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Warmers
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Incubators
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Incubators Neonatal Intensive Care Market by Type
  - 4.3.4.1 Hybrid Incubator Market size and forecast, by region
  - 4.3.4.2 Normal Incubator Market size and forecast, by region
  - 4.3.4.3 Transport Incubator Market size and forecast, by region
4.4 Monitoring Devices
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
4.5 Respiratory Devices
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
4.6 Phototherapy Equipment
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
4.7 Others
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market analysis by country

CHAPTER 5: NEONATAL INTENSIVE CARE MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Neonatal Hypothermia & Low Birth Weight
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Jaundice
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country

CHAPTER 6: NEONATAL INTENSIVE CARE MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Maternity Hospitals
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Neonatal & Pediatric Hospital
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: NEONATAL INTENSIVE CARE MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
  - 7.2.2.1 North America Incubators Neonatal Intensive Care Market by Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Product
  - 7.2.5.1.2 Market size and forecast, by Application
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Product
  - 7.2.5.2.2 Market size and forecast, by Application
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Product
  - 7.2.5.3.2 Market size and forecast, by Application
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
  - 7.3.2.1 Europe Incubators Neonatal Intensive Care Market by Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Product
  - 7.3.5.1.2 Market size and forecast, by Application
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Product
  - 7.3.5.2.2 Market size and forecast, by Application
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 UK
  - 7.3.5.3.1 Market size and forecast, by Product
  - 7.3.5.3.2 Market size and forecast, by Application
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Product
  - 7.3.5.4.2 Market size and forecast, by Application
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Product
  - 7.3.5.5.2 Market size and forecast, by Application
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Product
  - 7.3.5.6.2 Market size and forecast, by Application
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
  - 7.4.2.1 Asia-Pacific Incubators Neonatal Intensive Care Market by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 China
  - 7.4.5.1.1 Market size and forecast, by Product
  - 7.4.5.1.2 Market size and forecast, by Application
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 Japan
  - 7.4.5.2.1 Market size and forecast, by Product
  - 7.4.5.2.2 Market size and forecast, by Application
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 India
  - 7.4.5.3.1 Market size and forecast, by Product
  - 7.4.5.3.2 Market size and forecast, by Application
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 Australia
  - 7.4.5.4.1 Market size and forecast, by Product
  - 7.4.5.4.2 Market size and forecast, by Application
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Product
  - 7.4.5.5.2 Market size and forecast, by Application
  - 7.4.5.5.3 Market size and forecast, by End User
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Market size and forecast, by Product
  - 7.4.5.6.2 Market size and forecast, by Application
  - 7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
  - 7.5.2.1 LAMEA Incubators Neonatal Intensive Care Market by Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Product
  - 7.5.5.1.2 Market size and forecast, by Application
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Product
  - 7.5.5.2.2 Market size and forecast, by Application
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Product
  - 7.5.5.3.2 Market size and forecast, by Application
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Product
  - 7.5.5.4.2 Market size and forecast, by Application
  - 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Dragerwerk AG & Co. KGaA
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 GE Company
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 Masimo Corporation
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 3M Company
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 Phoenix Medical Systems Pvt Ltd.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Medtronic PLC
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Koninklijke Philips N.V
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Fanem Medical Devices
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Atom Medica
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 Mediprema Group
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
9.11 Siemens Healthcare GmbH
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
9.12 Terumo Corporation
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
9.13 Medicor Elektronika
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
9.14 Ningbo David Medical Device Co., Ltd.
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
9.15 Zhengzhou Dison Instrument And Meter Co., Ltd
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
9.16 AngioDynamics
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
9.17 Vygon (UK) Ltd
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments